blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2043704

EP2043704 - METHODS OF MANUFACTURING AND MODIFYING TAXANE COATINGS FOR IMPLANTABLE MEDICAL DEVICES [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  17.03.2017
Database last updated on 15.07.2024
Most recent event   Tooltip17.03.2017Change - German titlepublished on 19.04.2017  [2017/16]
17.03.2017Patent maintained (B2 publication)published on 19.04.2017  [2017/16]
Applicant(s)For all designated states
Cook Medical Technologies LLC
750 North Daniels Way
Bloomington, IN 47404 / US
[2012/04]
Former [2011/43]For all designated states
Cook Medical Technologies LLC
P.O. Box 2269
Bloomington, IN 47402 / US
Former [2009/15]For all designated states
Cook Incorporated
750 North Daniel's Way
Bloomington IN 47402-0489 / US
For all designated states
Med Institute, Inc.
1400 Cumberland Avenue
West Lafayette, IN 47906 / US
Inventor(s)01 / REYES, Priscilla T.
1950 Ellison Drive
West Lafayette, IN 47906 / US
02 / MOORE, William F.
5477 Farmers Drive
Bloomington, IN 47403 / US
03 / RUANE, Patrick
750 Bair Island Road, Bldg 5
Apt. 104
Redwood City, CA 94063 / US
04 / MYERS, Randy J.
7333 Whippoorwill Lane
Bloomington, IN 47401 / US
 [2017/16]
Former [2009/15]01 / REYES, Priscilla T.
1950 Ellison Drive
West Lafayette, IN 47906 / US
02 / MOORE, William F.
5477 Farmers Drive
Bloomington, IN 47403 / US
03 / RUANE, Patrick
750 Bair Island Road, Bldg 5 Apt. 104
Redwood City, CA 94063 / US
04 / MYERS, Randy J.
7333 Whippoorwill Lane
Bloomington, IN 47401 / US
Representative(s)Simpson, Tobias Rutger, et al
Mathys & Squire LLP The Shard
32 London Bridge Street
GB-London SE1 9SG / GB
[2017/16]
Former [2009/15]Garratt, Peter Douglas, et al
Mathys & Squire LLP 120 Holborn London
EC1N 2SQ / GB
Application number, filing date07810005.428.06.2007
[2009/15]
WO2007US15033
Priority number, dateUS20060818175P30.06.2006         Original published format: US 818175 P
US20060830726P13.07.2006         Original published format: US 830726 P
US20060830660P13.07.2006         Original published format: US 830660 P
[2009/15]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008005284
Date:10.01.2008
Language:EN
[2008/02]
Type: A2 Application without search report 
No.:EP2043704
Date:08.04.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 10.01.2008 takes the place of the publication of the European patent application.
[2009/15]
Type: B1 Patent specification 
No.:EP2043704
Date:10.08.2011
Language:EN
[2011/32]
Type: B2 New European patent specification 
No.:EP2043704
Date:19.04.2017
Language:EN
[2017/16]
Search report(s)International search report - published on:EP29.01.2009
ClassificationIPC:A61L31/16
[2009/15]
CPC:
A61L31/16 (EP); A61L2300/416 (EP); A61L2300/606 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/16]
Former [2009/15]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VERFAHREN ZUR HERSTELLUNG UND MODIFIZIERUNG VON TAXAN-BESCHICHTUNGEN FÜR IMPLANTIERBARE MEDIZINISCHE VORRICHTUNGEN[2017/16]
English:METHODS OF MANUFACTURING AND MODIFYING TAXANE COATINGS FOR IMPLANTABLE MEDICAL DEVICES[2009/15]
French:PROCÉDÉS DE PRODUCTION ET DE MODIFICATION DE REVÊTEMENTS EN TAXANE DESTINÉS À DES DISPOSITIFS MÉDICAUX IMPLANTABLES[2009/15]
Former [2009/15]VERFAHREN ZUR HERSTELLUNG UND MODIFIZIERUNG VON TAXAN-BESCHICHTUNGEN FÜR IMPLANTIERBARE MEDIZINISCHE VORRICHTUNGEN
Entry into regional phase23.12.2008National basic fee paid 
23.12.2008Designation fee(s) paid 
23.12.2008Examination fee paid 
Examination procedure23.12.2008Amendment by applicant (claims and/or description)
23.12.2008Examination requested  [2009/15]
09.06.2009Despatch of a communication from the examining division (Time limit: M06)
08.12.2009Reply to a communication from the examining division
08.02.2010Despatch of a communication from the examining division (Time limit: M04)
18.06.2010Reply to a communication from the examining division
28.02.2011Communication of intention to grant the patent
22.06.2011Fee for grant paid
22.06.2011Fee for publishing/printing paid
Divisional application(s)EP11167978.3  / EP2380606
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.06.2009
Opposition(s)Opponent(s)01  10.05.2012   
Boston Scientific Corporation
One Scimed Place MS A150
Maple Grove MN 55311 / US
Opponent's representative
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
 [N/P]
Former [2012/25]
Opponent(s)01  10.05.2012   
Boston Scientific Corporation
One Scimed Place MS A150
Maple Grove MN 55311 / US
Opponent's representative
Vossius & Partner
Siebertstrasse 4
81675 München / DE
15.06.2012Invitation to proprietor to file observations on the notice of opposition
17.12.2012Reply of patent proprietor to notice(s) of opposition
04.06.2013Date of oral proceedings
28.06.2013Despatch of minutes of oral proceedings
05.02.2016Despatch of a communication from the opposition division (Time limit: M02)
15.04.2016Reply to a communication from the opposition division
07.09.2016Despatch of interlocutory decision in opposition
17.09.2016Legal effect of interlocutory decision in opposition
19.12.2016Despatch of communication that the patent will be maintained as amended
10.02.2017Fee for printing new specification paid
Appeal following opposition07.10.2013Appeal received No.  T2128/13
10.12.2013Statement of grounds filed
18.06.2015Result of appeal procedure: maintenance in amended form
18.06.2015Date of oral proceedings
25.06.2015Minutes of the oral proceedings despatched
Fees paidRenewal fee
05.06.2009Renewal fee patent year 03
31.03.2010Renewal fee patent year 04
07.06.2011Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.06.2007
AT10.08.2011
BE10.08.2011
CY10.08.2011
CZ10.08.2011
DK10.08.2011
EE10.08.2011
FI10.08.2011
IT10.08.2011
LT10.08.2011
LV10.08.2011
MT10.08.2011
NL10.08.2011
PL10.08.2011
RO10.08.2011
SE10.08.2011
SI10.08.2011
SK10.08.2011
TR10.08.2011
BG10.11.2011
GR11.11.2011
ES21.11.2011
IS10.12.2011
PT12.12.2011
LU28.06.2012
CH30.06.2012
LI30.06.2012
MC30.06.2012
FR02.07.2012
[2014/34]
Former [2014/27]AT10.08.2011
BE10.08.2011
CY10.08.2011
CZ10.08.2011
DK10.08.2011
EE10.08.2011
FI10.08.2011
IT10.08.2011
LT10.08.2011
LV10.08.2011
MT10.08.2011
NL10.08.2011
PL10.08.2011
RO10.08.2011
SE10.08.2011
SI10.08.2011
SK10.08.2011
TR10.08.2011
BG10.11.2011
GR11.11.2011
ES21.11.2011
IS10.12.2011
PT12.12.2011
LU28.06.2012
CH30.06.2012
LI30.06.2012
MC30.06.2012
FR02.07.2012
Former [2014/21]AT10.08.2011
BE10.08.2011
CY10.08.2011
CZ10.08.2011
DK10.08.2011
EE10.08.2011
FI10.08.2011
IT10.08.2011
LT10.08.2011
LV10.08.2011
MT10.08.2011
NL10.08.2011
PL10.08.2011
RO10.08.2011
SE10.08.2011
SI10.08.2011
SK10.08.2011
TR10.08.2011
BG10.11.2011
GR11.11.2011
ES21.11.2011
IS10.12.2011
PT12.12.2011
CH30.06.2012
LI30.06.2012
MC30.06.2012
FR02.07.2012
Former [2013/35]AT10.08.2011
BE10.08.2011
CY10.08.2011
CZ10.08.2011
DK10.08.2011
EE10.08.2011
FI10.08.2011
IT10.08.2011
LT10.08.2011
LV10.08.2011
MT10.08.2011
NL10.08.2011
PL10.08.2011
RO10.08.2011
SE10.08.2011
SI10.08.2011
SK10.08.2011
BG10.11.2011
GR11.11.2011
ES21.11.2011
IS10.12.2011
PT12.12.2011
CH30.06.2012
LI30.06.2012
MC30.06.2012
FR02.07.2012
Former [2013/29]AT10.08.2011
BE10.08.2011
CY10.08.2011
CZ10.08.2011
DK10.08.2011
EE10.08.2011
FI10.08.2011
IT10.08.2011
LT10.08.2011
LV10.08.2011
NL10.08.2011
PL10.08.2011
RO10.08.2011
SE10.08.2011
SI10.08.2011
SK10.08.2011
BG10.11.2011
GR11.11.2011
ES21.11.2011
IS10.12.2011
PT12.12.2011
CH30.06.2012
LI30.06.2012
MC30.06.2012
FR02.07.2012
Former [2012/23]AT10.08.2011
BE10.08.2011
CY10.08.2011
CZ10.08.2011
EE10.08.2011
FI10.08.2011
IT10.08.2011
LT10.08.2011
LV10.08.2011
NL10.08.2011
PL10.08.2011
RO10.08.2011
SE10.08.2011
SI10.08.2011
SK10.08.2011
GR11.11.2011
IS10.12.2011
PT12.12.2011
Former [2012/21]AT10.08.2011
BE10.08.2011
CY10.08.2011
CZ10.08.2011
FI10.08.2011
LT10.08.2011
LV10.08.2011
NL10.08.2011
PL10.08.2011
SE10.08.2011
SI10.08.2011
GR11.11.2011
IS10.12.2011
PT12.12.2011
Former [2012/17]AT10.08.2011
BE10.08.2011
CY10.08.2011
FI10.08.2011
LT10.08.2011
LV10.08.2011
NL10.08.2011
PL10.08.2011
SE10.08.2011
SI10.08.2011
GR11.11.2011
IS10.12.2011
PT12.12.2011
Former [2012/12]AT10.08.2011
CY10.08.2011
FI10.08.2011
LT10.08.2011
LV10.08.2011
NL10.08.2011
PL10.08.2011
SE10.08.2011
SI10.08.2011
GR11.11.2011
IS10.12.2011
PT12.12.2011
Cited inInternational search[A]EP0717041  (BRISTOL MYERS SQUIBB CO [US]) [A] 1-19 * column 2, lines 10-24 *;
 [A]US6231600  (ZHONG SHENG-PING [US]) [A] 1-19 * example 7; claims 1-4,8,12 *;
 [A]US2004073284  (BATES BRIAN L [US], et al) [A] 1-19 * paragraph [0015]; claims 1-17 *;
 [E]WO2007106441  (COOK INC [US], et al) [E] 1-19* claims 1-24 *;
 [A]  - KAMATH K R ET AL, "The Taxus(TM) drug-eluting stent: A new paradigm in controlled drug delivery", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER BV, AMSTERDAM, NL, (20060306), vol. 58, no. 3, ISSN 0169-409X, pages 412 - 436, XP005481783 [A] 1-19 * page 417, paragraph 3 - page 422, paragraph 5 *

DOI:   http://dx.doi.org/10.1016/j.addr.2006.01.023
 [A]  - GI, U.-S., MIN, B., LEE, J.H., KIM, J.-H., "Preparation and characterization of paclitaxel from plant cell culture", KOREAN JOURNAL OF CHEMICAL ENGINEERING, (200407), vol. 21, no. 4, pages 816 - 820, XP002499326 [A] 1-19 * the whole document *

DOI:   http://dx.doi.org/10.1007/BF02705526
Examination   - LIGGINS R.T. ET AL., JOURNAL OF PHARMACEUTICAL SCIENCES, (19971201), vol. 86, no. 12, pages 1458 - 1463, XP009027537

DOI:   http://dx.doi.org/10.1021/js9605226
OppositionUS2002051730
 US2006215564
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.